About company
Alpha Cancer Technologies Inc. (ACT) is a private clinical stage biotechnology company with products under development in immunotherapy and immuno-oncology. The company’s drug products use our proprietary recombinant human alpha fetoprotein (AFP).
- Unknown
- isherman@alpha-cancer.com
- Unknown
- alpha-cancer.com/
- Not verified company
